Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance
Cancers · 09.05.2026 · 18 (10) · 1525
DOI: 10.3390/cancers18101525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 09.05.2026. Verfasst von Laura Valerio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci 16, 53100 Siena, Italy. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The clinical impact of familial history on the prognosis of non-medullary thyroid cancer (NMTC) remains controversial. This study aimed to investigate whether familial NMTC (fNMTC) is associated with different patterns of response-to-therapy evolution over time compared to sporadic NMTC (sNMTC), using a dynamic risk stratification (DRS) approach.
Methods
We analyzed 665 sNMTC cases and 130 fNMTC cases. Response to therapy was assessed at the first follow-up (6–12 months after initial therapy) and at the last outcome. Univariate and multivariate analyses were used to assess the role of family history as a modifier of response reclassification, independently of established prognostic factors.
Results
A significant difference in the dynamic pattern of response evolution was observed between fNMTC and sNMTC (p = 0.003), with familial cases showing higher response variability. Among patients with an initial excellent response (n = 558), familial status remained the only independent predictor of losing excellent response (OR 3.3, 95% CI 1.54–7.12; p = 0.002). The worsening in fNMTC was primarily driven by transitions to indeterminate or biochemical incomplete responses (12.3% vs. 4.2%, p = 0.006), while structural progression remained rare and similar between groups (2.5% vs. 1.3%, p = 0.33). Regarding recovery, 50.2% of patients with an initial non-excellent response achieved an excellent response, with no significant difference between familial and sporadic cases (61.2% vs. 47.3%, p = 0.1). An intermediate-to-high ATA risk class was independently associated with a lower probability of achieving an excellent response (OR 0.45, 95% CI 0.25–0.91; p = 0.01).
Conclusions
These findings suggest that “Excellent Response” is more fragile in a familial context. Familial NMTC might require prolonged and vigilant biochemical surveillance, even when cases appear to be in full remission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci 16, 53100 Siena, Italy.
- Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.
ORCID-Profile: Laura Valerio, Alfonso Sagnella, Fabio Maino, Alessandra Cartocci
Zitieren
APA
Valerio, L., Sagnella, A., Maino, F., Mattii, E., Cartocci, A., & Castagna, M. G. (2026). Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance. Cancers, 18(10), 1525. https://doi.org/10.3390/cancers18101525
Vancouver
Valerio L, Sagnella A, Maino F, Mattii E, Cartocci A, Castagna MG. Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance. Cancers. 2026;18(10):1525. doi:10.3390/cancers18101525
BibTeX
@article{Valerio2026,
author = {Valerio, Laura and Sagnella, Alfonso and Maino, Fabio and Mattii, Elisa and Cartocci, Alessandra and Castagna, Maria Grazia},
title = {Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance},
journal = {Cancers},
year = {2026},
volume = {18},
number = {10},
pages = {1525},
doi = {10.3390/cancers18101525}
}
EUVIMED